The drug shortage program, within the Center for Drug Evaluation and Research (CDER), addresses potential or actual shortages of prescription, over-the-counter, or generic drugs that have a significant impact on public health. http://www.fda.gov/cder/drug/shortages/default.htm en-us Fri, 11 Jul 2008 10:35 EDT cderwebmaster@fda.hhs.gov See website for more information about this resolved shortage. Fri, 11 Jul 2008 10:35 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Digoxin Baxter has discontinued Revex production. Wed, 09 Jul 2008 11:15 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Revex Availability information updated. Fri, 20 Jun 2008 15:20 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Fentanyl Hospira information updated. Fri, 20 Jun 2008 14:05 EDT http://www.fda.gov/cder/drug/shortages/mvi_hospira.htm Bedford has the 200 mcg vials (NDC 55390-0880-10) available. APP plans to have levothyroxine vials available again Tue, 09 Jun 2008 16:30 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Levothyroxine Cortisproin Otic Suspension (neomycin and polymyxin B sulfates and hydrocortisone otic suspension, USP), Dear Healthcare Professional Letter available for more information. Thu, 05 Jun 2008 14:30 EDT http://www.fda.gov/cder/drug/shortages/default.htm#CortisporinOtic Kemadrin (procyclidine hydrochloride), Dear Healthcare Professional Letter available for more information. Thu, 05 Jun 2008 12:25 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Kemadrin Cortisporin Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone ophthalmic suspension), Dear Healthcare Professional Letter available for more information. Thu, 05 Jun 2008 12:25 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Cortisporin Intal Nebulizer Solution (cromolyn sodium inhalation solution, USP. Dear Healthcare Professional Letter is available for more information. Mon, 02 Jun 2008 16:10 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Intal After December 31, 2008, albuterol CFC MDIs are prohibited from being sold or distributed in the United States. Therefore, patients are encouraged to talk with their health care providers now to begin the transition to an HFA propelled albuterol MDI. After the transition is complete, it is anticipated that supplies of albuterol HFA and levalbuterol HFA MDIs will continue to meet the total market demand. FDA is working closely with manufacturers to ensure that there is adequate supply of the HFA propelled albuterol and levalbuterol MDI products available. (more information) Fri, 30 May 2008 16:15 EDT http://www.fda.gov/cder/drug/shortages/default.htm#albuterol Resolved Drug Shortage: Leukine (sargramostim) liquid 500 mcg vial Thu, 29 May 2008 12:05 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Leukine Actavis Totowa (formerly known as Amide Pharmaceutical, Inc.) recalled of all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP). Other manufacturers of digoxin tablets are available and listed on the Drug Shortage website. Mon, 12 May 2008 16:00 EDT http://www.fda.gov/cder/drug/shortages/default.htm#Digitek